Figure 5. Treatment with increasing doses of the EG complex inhibited NF-κB activity in human cells induced with TNF-α (20 ng/mL); * = statistically significant.

This inhibition was dose-dependent (see Figure 5) and statistically significant at all concentrations used (z < 1.96, Wilcoxon test), with a max inhibition at 1.1% (-85% vs cytokine mix-induced).